CFDA releases 2018 legislative plan

China FDA published a legislative road map for 2018 that outlines the agency’s plans to revise drug laws and regulations as well as develop guidance documents.

Among the legislative projects in the 2018 plan, CFDA proposes to make amendments to the country's drug administration law and to review laws concerning drug patents. The road map includes plans for draft or revised guidance for good clinical practices as well as the registration of medical devices and in vitro diagnostics. It also includes plans to develop and revise regulations covering medical device supervision, cosmetics supervision and food safety...